Real-world Impact of TAILORx on Chemotherapy Use and SOFT/TEXT on Ovarian Function Suppression Uptake in a Population Based-Cohort of Women 40 Years and under with HR-positive, HER2-negative, Axillary Lymph Node Negative Breast Cancer.